SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Spain

SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in
Spain

SAN DIEGO, June 24 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC
Bulletin Board: SCIE), a San Diego based medical device company, today
announced that it has established a distribution partnership in the Spanish
market through SIM, a Madrid based firm specializing in the marketing and
distribution of innovative medical devices.

Michel Vaudry, SpectraScience's VP of Sales and Marketing, said, "We are
pleased to add another distribution partner in Europe. SIM is a respected and
well established medical distribution company and adding the WavSTAT Optical
Biopsy System to their portfolio is a strong validation of the need for our
technology. SIM was established in 2000 and distributes other leading
gastroenterological diagnostic products from market leaders including PENTAX
and ERBE."

SIM's Consejero Delegado, Jose Manuel Ruiz, stated that, "We are pleased to be
SpectraScience's distribution partner and believe there is significant market
potential for this innovative gastrointestinal cancer diagnostic system. Our
strategy is to be the leader in gastro-diagnostics and the WavSTAT Optical
Biopsy System is an ideal fit with our PENTAX endoscopes. We see important
benefits to our physicians, enabling them to quickly distinguish between
normal and precancerous tissue in the GI tract and allowing for physical
biopsy at exactly the same site and time that an optical biopsy is performed.
More importantly, the WavSTAT objectively identifies the borders of tissue
during surgery to determine if all cancerous tissue has been removed. This
can prevent additional costly treatment."

Vaudry added, "Mr. Ruiz is a respected thought leader in the healthcare market
and his company's support of the WavSTAT System will be instrumental in our
acceptance at the major gastroenterology centers in Spain. SIM is a perfect
partner for SpectraScience as they also represent PENTAX. PENTAX is one of
the leading manufacturers of endoscopes which are used in conjunction with our
product."

This news release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking statements
involve risks and uncertainties that may cause SpectraScience's actual results
to differ materially from results discussed in forward-looking statements.
Readers are urged to carefully review and consider the various disclosures
made by SpectraScience in this news release, its most recent Form 10-K and in
SpectraScience's other reports filed with the Securities and Exchange
Commission ("SEC") that attempt to advise interested parties of the risks and
factors that may affect SpectraScience's business. These forward-looking
statements are qualified in their entirety by the cautions and risk factors
filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs,
develops, manufactures and markets spectrophotometry systems capable of
determining whether tissue is normal, pre-cancerous or cancerous without
physically removing tissue from the body. The WavSTAT Optical Biopsy System
uses light to optically scan tissue and provides the physician with an
immediate analysis. With FDA approval for sale in the U.S. and the CE Mark
for the European Union, the WavSTAT System is the first commercially available
product that incorporates this innovative technology for clinical use. In
addition, the Company's LUMA(R) Cervical Imaging technology has received FDA
approval as an optical non-invasive system that is proven to more effectively
detect cervical cancer precursors than conventional methods available today.

Contact:

SpectraScience, Inc. Hayden Communications
Jim Hitchin, Chief Executive Officer Investor Relations
(858) 847-0200 x 201 Todd Pitcher
http://www.spectrascience.com (858)-518-1387

SOURCE SpectraScience, Inc.

Jim Hitchin, Chief Executive Officer of SpectraScience, Inc., +1-858-847-0200,
ext. 201; or Investor Relations, Todd Pitcher of Hayden Communications,
+1-858-518-1387, for SpectraScience, Inc.